{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:10:25Z","timestamp":1790291425980,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.hoc.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T19:00:48Z","timestamp":1530817248000},"page":"657-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia"],"prefix":"10.1016","volume":"32","author":[{"given":"Sharon A.","family":"Savage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.hoc.2018.04.002_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.hoc.2018.04.002_bib2","series-title":"Fanconi anemia reserach fund. Guidelines for diagnosis and management, 2008","year":"2008"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib3","first-page":"615","article-title":"Fanconi's anaemia in adults: study of three families","volume":"62","author":"Perona","year":"1977","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.hoc.2018.04.002_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng1458","article-title":"X-linked inheritance of Fanconi anemia complementation group B","volume":"36","author":"Meetei","year":"2004","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.hoc.2018.04.002_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng1196-324","article-title":"Positional cloning of the Fanconi anaemia group A gene","volume":"14","author":"Fanconi anaemia\/Breast cancer consortium","year":"1996","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.hoc.2018.04.002_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1097-2765(01)00172-1","article-title":"Positional cloning of a novel Fanconi anemia gene, FANCD2","volume":"7","author":"Timmers","year":"2001","journal-title":"Mol Cell"},{"issue":"6385","key":"10.1016\/j.hoc.2018.04.002_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/358434a0","article-title":"Cloning of cDNAs for Fanconi's anaemia by functional complementation","volume":"358","author":"Strathdee","year":"1992","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.hoc.2018.04.002_bib8","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0002-9297(07)62959-0","article-title":"Isolation of a cDNA representing the Fanconi anemia complementation group E gene","volume":"67","author":"de Winter","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/71626","article-title":"The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM","volume":"24","author":"de Winter","year":"2000","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.hoc.2018.04.002_bib10","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/MCB.19.7.4866","article-title":"Fanconi anemia proteins FANCA, FANCC, and FANCG\/XRCC9 interact in a functional nuclear complex","volume":"19","author":"Garcia-Higuera","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.hoc.2018.04.002_bib11","first-page":"211","article-title":"Identification of the Fanconi anemia complementation group I gene, FANCI","volume":"29","author":"Dorsman","year":"2007","journal-title":"Cell Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nsmb1252","article-title":"FANCI is a second monoubiquitinated member of the Fanconi anemia pathway","volume":"14","author":"Sims","year":"2007","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"10.1016\/j.hoc.2018.04.002_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2007.03.009","article-title":"Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair","volume":"129","author":"Smogorzewska","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00304-X","article-title":"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function","volume":"105","author":"Cantor","year":"2001","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.hoc.2018.04.002_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1241","article-title":"A\u00a0novel ubiquitin ligase is deficient in Fanconi anemia","volume":"35","author":"Meetei","year":"2003","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","article-title":"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2","volume":"22","author":"Xia","year":"2006","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2009.06.030","article-title":"Mammalian BTBD12\/SLX4 assembles a Holliday junction resolvase and is required for DNA repair","volume":"138","author":"Svendsen","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.hoc.2018.04.002_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajhg.2013.04.002","article-title":"Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia","volume":"92","author":"Bogliolo","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.hoc.2018.04.002_bib19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1101\/gr.140200","article-title":"Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem\/progenitor cells","volume":"10","author":"Zhang","year":"2000","journal-title":"Genome Res"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ajhg.2015.04.022","article-title":"Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia","volume":"96","author":"Hira","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.hoc.2018.04.002_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0888-7543(95)80187-Q","article-title":"Assignment of the XRCC2 human DNA repair gene to chromosome 7q36 by complementation analysis","volume":"26","author":"Jones","year":"1995","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.hoc.2018.04.002_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jmedgenet-2011-100585","article-title":"Exome sequencing reveals a novel Fanconi group defined by XRCC2 mutation","volume":"49","author":"Shamseldin","year":"2012","journal-title":"J\u00a0Med Genet"},{"issue":"5285","key":"10.1016\/j.hoc.2018.04.002_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.274.5285.246","article-title":"Identification of a human mitotic checkpoint gene: hsMAD2","volume":"274","author":"Li","year":"1996","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.hoc.2018.04.002_bib24","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1172\/JCI88010","article-title":"Biallelic inactivation of REV7 is associated with Fanconi anemia","volume":"126","author":"Bluteau","year":"2016","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.hoc.2018.04.002_bib25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ng1626","article-title":"A\u00a0human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M","volume":"37","author":"Meetei","year":"2005","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.hoc.2018.04.002_bib26","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1172\/JCI92069","article-title":"Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia","volume":"127","author":"Knies","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hoc.2018.04.002_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2015.07.002","article-title":"Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics","volume":"33","author":"Bogliolo","year":"2015","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"10.1016\/j.hoc.2018.04.002_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng.570","article-title":"Mutation of the RAD51C gene in a Fanconi anemia-like disorder","volume":"42","author":"Vaz","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2018.04.002_bib29","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1038\/ncomms9829","article-title":"A\u00a0novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51","volume":"6","author":"Ameziane","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.hoc.2018.04.002_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40246-015-0054-y","article-title":"Update of the human and mouse Fanconi anemia genes","volume":"9","author":"Dong","year":"2015","journal-title":"Hum Genomics"},{"issue":"18","key":"10.1016\/j.hoc.2018.04.002_bib31","doi-asserted-by":"crossref","first-page":"R986","DOI":"10.1016\/j.cub.2017.07.043","article-title":"Fanconi anemia pathway","volume":"27","author":"Rodriguez","year":"2017","journal-title":"Curr Biol"},{"issue":"2","key":"10.1016\/j.hoc.2018.04.002_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/cr040478b","article-title":"Formation and repair of interstrand cross-links in DNA","volume":"106","author":"Noll","year":"2006","journal-title":"Chem Rev"},{"issue":"9","key":"10.1016\/j.hoc.2018.04.002_bib33","first-page":"768","article-title":"Primary heamorrhagic thrombocythaemia","volume":"51","author":"Shaw","year":"1958","journal-title":"Proc R Soc Med"},{"issue":"2","key":"10.1016\/j.hoc.2018.04.002_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","article-title":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","volume":"54","author":"Savage","year":"2017","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2018.04.002_bib35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1172\/JCI92946","article-title":"Biallelic inactivation of REV7 is associated with Fanconi anemia","volume":"127","author":"Bluteau","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib36","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ajmg.a.37637","article-title":"Thinking of VACTERL-H? Rule out Fanconi anemia according to PHENOS","volume":"170","author":"Alter","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"7","key":"10.1016\/j.hoc.2018.04.002_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archotol.131.7.635","article-title":"Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism","volume":"131","author":"Alter","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm.2016.48","article-title":"The Fanconi anaemia pathway: new players and new functions","volume":"17","author":"Ceccaldi","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"10.1016\/j.hoc.2018.04.002_bib39","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"issue":"9431","key":"10.1016\/j.hoc.2018.04.002_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing","volume":"364","author":"Risitano","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hoc.2018.04.002_bib41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2002-01-0035","article-title":"Intracellular interferon-gamma in circulating and marrow T\u00a0cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia","volume":"100","author":"Sloand","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2018.04.002_bib42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1365-2141.2001.03212.x","article-title":"Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia","volume":"115","author":"Dufour","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib43","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in\u00a0vitro","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2018.04.002_bib44","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1073\/pnas.112218799","article-title":"Chromosome translocations and covert leukemic clones are generated during normal fetal development","volume":"99","author":"Mori","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V88.1.49.49","article-title":"Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene","volume":"88","author":"Whitney","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2012.05.013","article-title":"Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells","volume":"11","author":"Ceccaldi","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"7354","key":"10.1016\/j.hoc.2018.04.002_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10192","article-title":"Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice","volume":"475","author":"Langevin","year":"2011","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.hoc.2018.04.002_bib48","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2013-06-507962","article-title":"Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients","volume":"122","author":"Hira","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after 15 years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.hoc.2018.04.002_bib50","first-page":"4064","article-title":"Association of complementation group and mutation type with clinical outcome in Fanconi anemia. European Fanconi Anemia Research Group","volume":"96","author":"Faivre","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2018.04.002_bib51","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A\u00a020-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2018.04.002_bib52","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2002-10-3243","article-title":"Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor","volume":"101","author":"Tonnies","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1309\/AJCP7W9VMJENZOVG","article-title":"Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi anemia: morphologic and cytogenetic characteristics","volume":"133","author":"Cioc","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"23","key":"10.1016\/j.hoc.2018.04.002_bib54","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2018.04.002_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","article-title":"Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2","volume":"44","author":"Alter","year":"2007","journal-title":"J\u00a0Med Genet"},{"issue":"3","key":"10.1016\/j.hoc.2018.04.002_bib56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/pbc.23168","article-title":"The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1\/BRCA2 mutations","volume":"58","author":"Myers","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2018.04.002_bib57","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2003-09-3138","article-title":"Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia","volume":"103","author":"Wagner","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2018.04.002_bib58","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.bbmt.2016.06.018","article-title":"Preemptive bone marrow transplantation and event-free survival in Fanconi anemia","volume":"22","author":"Khan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"10.1016\/j.hoc.2018.04.002_bib59","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2012.45.9719","article-title":"Allogeneic hematopoietic cell transplantation for Fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia","volume":"31","author":"Ayas","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2018.04.002_bib60","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2007.06975.x","article-title":"Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia","volume":"140","author":"Chaudhury","year":"2008","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.hoc.2018.04.002_bib61","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood-2015-02-626002","article-title":"Alternative donor hematopoietic cell transplantation for Fanconi anemia","volume":"125","author":"MacMillan","year":"2015","journal-title":"Blood"},{"issue":"1 Suppl","key":"10.1016\/j.hoc.2018.04.002_bib62","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.bbmt.2010.11.027","article-title":"Cellular therapy for Fanconi anemia: the past, present, and future","volume":"17","author":"MacMillan","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.hoc.2018.04.002_bib63","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbmt.2011.01.001","article-title":"Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning","volume":"17","author":"Stepensky","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"10.1016\/j.hoc.2018.04.002_bib64","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2016-09-743112","article-title":"Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study","volume":"129","author":"Mehta","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2018.04.002_bib65","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1158\/1078-0432.CCR-17-0465","article-title":"Recommendations for childhood cancer screening and surveillance in DNA repair disorders","volume":"23","author":"Walsh","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.hoc.2018.04.002_bib66","first-page":"278","article-title":"Treatment of aplastic anemia in children","volume":"4","author":"Diamond","year":"1967","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2018.04.002_bib67","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM196105112641901","article-title":"Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases","volume":"264","author":"Shahidi","year":"1961","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2018.04.002_bib68","unstructured":"Guidelines FA. Chapter 3: hematologic abnormalities in patients with Fanconi anemia. 2014."},{"issue":"21","key":"10.1016\/j.hoc.2018.04.002_bib69","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2018.04.002_bib70","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hoc.2018.04.002_bib71","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate-penetrance cancer-susceptibility mutations","volume":"13","author":"Tung","year":"2016","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985881830710X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985881830710X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:11:59Z","timestamp":1760184719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985881830710X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S088985881830710X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.04.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}